Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Andrew Berman currently holds 200,000 shares of Hancock Jaffe Laboratories, Inc. (HJLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Andrew Berman has been a net seller of HJLI stock. They have purchased $252.8K and sold $1.3M worth of shares.
Robert Andrew Berman's most recent insider trade was on Dec 18, 2024, when they sold 200,000 shares at $0.00 per share.
Robert Andrew Berman serves as Executive at Hancock Jaffe Laboratories, Inc. (HJLI). They have executed 64 insider transactions totaling $1.6M over their tenure at the company.
Robert Andrew Berman holds the position of Executive at Hancock Jaffe Laboratories, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Robert Andrew Berman has shown a selling trading pattern, with $252.8K in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert Andrew Berman was on Feb 9, 2007, when they sold $31.5K worth of ACTG/CBMX shares. This transaction involved 2,100 shares at $15.00 per share.
Robert Andrew Berman currently owns 200,000 shares of Hancock Jaffe Laboratories, Inc. (HJLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Andrew Berman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Andrew Berman has 64 Form 4 filings on record as an insider at Hancock Jaffe Laboratories, Inc..
Set alerts for Robert Andrew Berman and 40,000+ other insiders.